Efficacy and safety of telitacicept in patients with lupus nephritis: a single-center, real-world retrospective study

ConclusionsTelitacicept treatment reduced disease severity in patients with LN. The initial clinical trial provided supportive evidence for the effectiveness and safety of Telitacicept as a viable treatment option for LN, allowing a reduction in the daily glucocorticoid intake while maintaining a good safety profile, and improving hypocomplementation in LN management.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research